MedTrace Logo

Impact of Probiotics Supplement on the Gut Microbiota in Caesarean-born Infants

NCT05086458 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-10-21

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of probiotics on the gut microbiota of infants born by cesarean section.

Conditions

  • Gut Microbiota

Interventions

DIETARY_SUPPLEMENT

probiotics

probiotics blend of Bifidobacterium longum, Lactobacillus acidophilus, Enterococcus faecalis

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Huanlong Qin, MD · Shanghai 10th People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Hour
Max Age
42 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-17
Primary Completion
2021-10-17
Completion
2021-10-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05086458 on ClinicalTrials.gov